Cyclacel Pharmaceuticals, Inc.
(NASDAQ : CYCC)

( )
CYCC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.10%345.400.0%$4305.01m
BNTXBioNTech SE 1.44%296.610.0%$823.83m
NVAXNovavax, Inc. -1.10%133.5079.4%$750.42m
AMGNAmgen, Inc. 0.00%208.681.4%$526.19m
REGNRegeneron Pharmaceuticals, Inc. 0.00%592.152.7%$478.99m
SNSSSunesis Pharmaceuticals, Inc. 0.00%6.210.7%$434.10m
GILDGilead Sciences, Inc. -0.66%67.281.0%$395.23m
CCXIChemoCentryx, Inc. -0.83%33.442.9%$383.29m
ILMNIllumina, Inc. 0.00%417.193.3%$357.19m
XLRNAcceleron Pharma, Inc. 0.00%173.785.3%$335.39m
OCGNOcugen, Inc. -1.09%9.050.0%$300.03m
VRTXVertex Pharmaceuticals, Inc. 0.23%184.501.9%$274.69m
BIIBBiogen, Inc. 0.00%271.121.8%$271.81m
XENEXenon Pharmaceuticals, Inc. 0.00%30.570.4%$164.85m
CRSPCRISPR Therapeutics AG 0.05%95.110.6%$159.15m

Company Profile

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.